Pneumococcal bacteremia in a single center in Argentina

International Journal of Infectious Diseases

Volumn 8, Issue 1, 2004, Pages 53-58

  Altclas, Javier ^a   Salgueira, Claudia ^a   Di Martino, Ana ^a  

^a Sanatorio Mitre   (Argentina)

Author keywords

Bacteremia; Mortality; Streptococcus pneumoniae; Susceptibility

Indexed keywords

CEFTRIAXONE;

ADOLESCENT; ADULT; ANTIBIOTIC THERAPY; ARGENTINA; ARTICLE; BACTEREMIA; BACTERIAL COLONIZATION; CHILD; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; PATHOGENICITY; PATIENT CARE; PROSPECTIVE STUDY; SEROTYPE; SPECIES DIFFERENTIATION; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE;

EID: 0347087564     PISSN: 12019712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijid.2003.04.002     Document Type: Article

References (35)

1. Burman LA, Norrby R, Trufors B. Invasive pneumococcal infections. Incidence, predisposing factors and prognosis. Rev Infect Dis 1985;7:33-142.
2. Schapiro ED, Berg AT, Austian R, et al. The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. N Engl J Med 1991;325:453-60.
3. Musher DM. Infections caused by Streptococcus pneumoniae: clinical spectrum, pathogenesis, immunity and treatment. Clin Infect Dis 1992;14:801-9.
4. Friedland I, Mc Cracken G. Management of infections caused by antibiotic resistant Streptococcus pneumoniae. N Engl J Med 1994;331:377-82.
5. Klugman KP. Pneumococcal resistance to antibiotics. Clin Microbiol Rev 1990;3:171-96.
6. Marton A. Pneumococcal antimicrobial resistance: the problem in Hungary. Clin Infect Dis 1992;15:106-11.
7. Jacobs MR. Drug-resistant Streptococcus pneumoniae: rational antibiotic choice. Am J Med 1999;106(5A):19S-25S.
8. Baumen RF, Butter JC, Tenover FC, et al. Emergence of drug-resistant pneumococcal infections in the United States. JAMA 1994;271:1831-5.
9. Baquero F. Pneumococcal resistance to beta-lactam antibiotics: a global geographic overview. Microb Drug Resist 1995;1:115-20.
10. Buttler JC, Hofmann J, Cetron MS. The continued emergence of drug-resistant Streptococcus pneumoniae in the United States: an update from the Centers for Disease Control and Prevention's Pneumococcal Sentinel Surveillance System. J Infect Dis 1996;174:986-93.
11. Rossi A, Ruvinsky R, Regueira M. Distribution of capsular types and penicillin-resistance of strains of Streptococcus pneumoniae causing systemic infections in Argentinian children under 5 years of age. Microb Drug Resist 1997;3: 135-9.
12. Rossi A, Corso A, Pace J, et al. Penicillin-resistant Streptococcus pneumoniae in Argentina: frequent occurrence of an internationally spread serotype 14 clone. Microb Drug Resist 1998;4:225-31.
13. Kertesz DA, Fabio JL, Cunto Brandileone MC, et al. Invasive Streptococcus pneumoniae infection in Latin American children: results of the Pan American Health Organization Surveillance Study. Clin Infect Dis 1998;26:1355-61.
14. , Deeks SL, Palacio R, Ruvinsky R, et al. Risk factors and course of illness among children with invasive penicillin-resistant Streptococcus pneumoniae. Pediatrics 1999;2:409-13.
15. Rossi A, Tokumoto M, Glas M. Monitoring antibiotic resistance in Argentina. The WHONET program, 1995-1996. Rev Panam Salud Publica 1999;6:234-41.
16. Facklam RR, Carey RB. Streptococci and aerococci. In: Balows A, Hausler WJ Jr. Shadomy HJ, editors. Manual of clinical microbiology. 4th ed. Washington DC: 1992, p. 154-75.
17. National Committee for Clinical Laboratory Standards (NC-CLS). Performance standards for antimicrobial disk susceptibility tests. Approved standard, 7th ed. M2-A7 Vol 20, No 1. January 2000.
18. Plouffle JF, Breiman RF, Facklam R, et al. Bacteremia with Streptococcus pneumoniae. Implications for therapy and prevention. JAMA 1996;17:194-8.
19. Finkelstein MS, Petkun W, Freedman ML, et al. Pneumococcal bacteremia in adults: age-dependent differences in presentation and in outcome. J Am Geriatr Soc 1983;31:19-27.
20. Rahav G, Toledano Y, Engelhard D. Invasive pneumococcal infections. A comparison between adults and children. Medicine (Baltimore) 1997;76:295-303.
21. Carey I, Glauser MP, Billie J. Pneumococcal bacteremia: what is new? Schweiz Med Wochenschr 1995;125:952-8.
22. Rubins JB, Cheung SP, Carson et al. Identification of clinical risk factors for nosocomial pneumococcal bacteremia. Clin Infect Dis 1999;29:178-83.
23. Afessa B, Greaves WL, Frederich WR. Pneumococcal bacteremia in adults: a 14 years experience in an Inner-City University Hospital. Clin Infect Dis 1995;21:345-51.
24. Raz R, Elhanan G, Simón Z, Kitzes R. Pneumococcal bacteremia in hospitalized Israeli adults: epidemiology and resistance to penicillin. Clin Infect Dis 1997;24:1164-8.
25. Musherf D. Pneumococcal infections. In: Braunwald E, Fauci A, Kasper DL, editors. Harrison's principles of internal medicine. 15th ed. New York: Mc Graw-Hill; 2001, Chapter 138.
26. Clavo-Sanchez AJ, Giron-Gonzalez JA, Lopez-Prieto D, et al. Multivariate analysis of risk factors for infection due to penicillin-resistant and multidrug-resistant Streptococcus pneumoniae: a multicenter study. Clin Infect Dis 1997;24:1052-9.
27. Butler JC, Cetron MS. Pneumococcal drug resistance: the new 'special enemy of old age'. Clin Infect Dis 1999;28:730-5.
28. Pallares R, Gudiol F, Liñares J, et al. Risk factors and response to antibiotic therapy in adults with bacteremic pneumonia caused by penicillin-resistant pneumococci. N Engl J Med 1987;317:18-22.
29. Nava JM, Bella F, Garau et al. Predictive factors for invasive disease due to penicillin resistant Streptococcus pneumoniae: a population based study. Clin Infect Dis 1994;19:884-90.
30. Pallares R, Liñares J, Vadillo M, et al. Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. N Engl J Med 1995;333:474-80.
31. Silverstein M, Bauchur R, Harper MB. Clinical implications of penicillin and ceftriaxone resistance among children with pneumococcal bacteremia. Pediatr Infect Dis J 1999;18:35-41.
32. Turett GS, Blum S, Fazal BA, et al. Penicillin resistance and other predictors of mortality in pneumococcal bacteremia in a population with high human immunodeficiency virus seroprevalence. Clin Infect Dis 1999;29:321-7.
33. Frankel RE, Virata M, Hardalo C, et al. Invasive pneumococcal disease: clinical features, serotypes, and antimicrobial resistance patterns in cases involving patients with and without human immunodeficiency virus infection. Clin Infect Dis 1996;23:577-84.
34. Hook EW, Horton CA, Schaberg DR. Failure of intensive care unit support to influence mortality from pneumococcal bacteremia. JAMA 1983;249:1055-7.
35. Mirzanejad Y, Roman S, Talbot J, et al. Pneumococcal bacteremia in two tertiary care hospitals in Winnipeg, Canada. Chest 1996;109:173-8.